Product NDC: | 0703-3019 |
Proprietary Name: | ADRUCIL |
Non Proprietary Name: | fluorouracil |
Active Ingredient(s): | 5 g/100mL & nbsp; fluorouracil |
Administration Route(s): | INTRAVENOUS |
Dosage Form(s): | INJECTION |
Coding System: | National Drug Codes(NDC) |
Product NDC: | 0703-3019 |
Labeler Name: | Teva Parenteral Medicines, Inc. |
Product Type: | HUMAN PRESCRIPTION DRUG |
FDA Application Number: | ANDA040334 |
Marketing Category: | ANDA |
Start Marketing Date: | 20031001 |
Package NDC: | 0703-3019-12 |
Package Description: | 5 VIAL in 1 TRAY (0703-3019-12) > 100 mL in 1 VIAL (0703-3019-11) |
NDC Code | 0703-3019-12 |
Proprietary Name | ADRUCIL |
Package Description | 5 VIAL in 1 TRAY (0703-3019-12) > 100 mL in 1 VIAL (0703-3019-11) |
Product NDC | 0703-3019 |
Product Type Name | HUMAN PRESCRIPTION DRUG |
Non Proprietary Name | fluorouracil |
Dosage Form Name | INJECTION |
Route Name | INTRAVENOUS |
Start Marketing Date | 20031001 |
Marketing Category Name | ANDA |
Labeler Name | Teva Parenteral Medicines, Inc. |
Substance Name | FLUOROURACIL |
Strength Number | 5 |
Strength Unit | g/100mL |
Pharmaceutical Classes | Nucleic Acid Synthesis Inhibitors [MoA],Nucleoside Metabolic Inhibitor [EPC] |